Article: FDA Criticizes Alcon Eye Drug Production Line in Fort Worth, Texas.(Knight Ridder/Tribune Business News)

Dec. 12--FORT WORTH, Texas--Alcon Laboratories, which makes eye drugs and other eye-care products, has received a warning letter from the Food and Drug Administration, citing problems with one of its production lines at its headquarters in Fort Worth.

The letter, delivered Nov. 17 to Alcon President and Chief Executive Tim Sear, says FDA investigators had documented "serious deviations" from good manufacturing practices.

Mary Dulle, a spokeswoman for Alcon, said the company has addressed the concerns and informed the FDA of its actions.

A spokeswoman for the FDA office in Dallas said the investigation remains open until the agency can determine ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!